Alphatec (ATEC) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SI-BONE (SIBN) has outperformed Alphatec (ATEC) over the past year, gaining 21.7% versus a loss of 67.1%. Over five years, SIBN leads with a +18.5% price change compared with -36.8% for ATEC. SI-BONE is the larger company by market cap ($1.07 billion vs $1.02 billion), about 1.0 times the size, while Alphatec is growing revenue faster (+25.0% vs +20.2%).
SI-BONE converts more of its revenue into profit, with a net margin of -9.4% versus -18.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATEC | SIBN |
|---|---|---|
| Share price | $6.68 | $23.73 |
| Market cap | $1.02B | $1.07B |
| 1-day change | -3.19% | -0.08% |
| YTD return | -68.25% | +20.33% |
| 1-year return | -67.11% | +21.69% |
| 5-year return | -36.80% | +18.53% |
| Forward P/E | 11.97 | — |
| EPS (TTM) | $-0.57 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $764.15M | $200.93M |
| Revenue growth (YoY) | +24.95% | +20.19% |
| Net income (latest FY) | $-143.36M | $-18.90M |
| Gross margin | 69.60% | 79.57% |
| Operating margin | -10.75% | -11.11% |
| Net margin | -18.76% | -9.41% |
| 52-week high | $23.29 | $25.92 |
| 52-week low | $6.63 | $11.48 |
| Distance from 52-week high | -71.32% | -8.45% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +93.56% | +12.85% |
| Average volume | 3.38M | 709.79K |
| Shares outstanding | 153.33M | 45.11M |
| Employees | 913 | 376 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SIBN has outperformed ATEC by 88.8 percentage points over the past year.
- SI-BONE is more profitable, keeping -9.4 cents of every revenue dollar as net income versus -18.8 cents for Alphatec.
About Alphatec
ATEC stock →Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
Health Care · Medical/Dental Instruments · 913 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
ATEC vs SIBN FAQ
Which is bigger, Alphatec or SI-BONE?
SI-BONE (SIBN) is larger, with a market capitalization of $1.07B compared with $1.02B for Alphatec (ATEC).
Which stock has performed better over the past year, ATEC or SIBN?
SIBN returned +21.69% over the past 12 months, compared with -67.11% for ATEC (price return, excluding dividends). Past performance does not predict future results.
Are Alphatec and SI-BONE in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.